| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/18/2013 | CN101228181B Hcv ns3蛋白酶抑制剂 Hcv ns3 protease inhibitors |
| 09/17/2013 | US8536348 Lactone formulations and method of use |
| 09/17/2013 | US8536136 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 09/17/2013 | US8536114 Macrocycles |
| 09/17/2013 | US8535731 Use of extracts of the Cassia alata plant |
| 09/17/2013 | US8535728 Colloidal silver composition having antimicrobial properties |
| 09/17/2013 | US8535688 Vaccine |
| 09/17/2013 | US8535646 Method of inhibiting harmful microorganisms and barrier-forming composition therefor |
| 09/17/2013 | CA2775616C Salts of benzimidazole compound and application thereof |
| 09/17/2013 | CA2632626E Ester prodrugs of 2'-fluoro-2'-alkyl-2'-deoxycytidines and their use in the treatment of hcv infection |
| 09/17/2013 | CA2591673C Compositions comprising extracts from sanguinaria or macleaya |
| 09/17/2013 | CA2562685C Single-stranded and double-stranded oligonucleotides comprising a 2-arylpropyl moiety |
| 09/17/2013 | CA2482946C Multi plasmid system for the production of influenza virus |
| 09/17/2013 | CA2451738C Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals using 2-amino-2'-deoxyadenosine |
| 09/17/2013 | CA2445381C Phosphorous antimicrobial compounds and methods for their use |
| 09/17/2013 | CA2348382C Chimeric parvovirus vectors and methods of making and administering the same |
| 09/12/2013 | WO2013134626A1 Prevention and treatment of respiratory infection with peroxisome proliferator activator receptor delta agonist |
| 09/12/2013 | WO2013134562A1 Triazolone compounds and uses thereof |
| 09/12/2013 | WO2013134416A1 Use of the chromosome 19 microrna cluster (c19mc) for treating microbial disease and promoting authophagy |
| 09/12/2013 | WO2013134415A1 Mannose derivatives for treating bacterial infections |
| 09/12/2013 | WO2013134225A1 Multivalent vaccine protection from staphylococcus aureus infection |
| 09/12/2013 | WO2013134146A1 Methods and compositions for treating viral infections by blocking type i interferon activity |
| 09/12/2013 | WO2013134142A1 Inhibitors of human immunodeficiency virus replication |
| 09/12/2013 | WO2013134113A1 Fused pyrimidines as inhibitors of immunodeficiency virus replication |
| 09/12/2013 | WO2013133927A1 Pharmaceutical compositions of 2'-c-methyl-guanosine, 5'-[2-[(3-hydroxy-2,2-dimethyl-1-oxopropyl)thio]ethyl n-(phenylmethyl)phosphoramidate] |
| 09/12/2013 | WO2013133325A1 Tricyclic compound |
| 09/12/2013 | WO2013132444A1 Fulvic acid and antibiotic combination for the inhibition or treatment of multi-drug resistant bacteria |
| 09/12/2013 | WO2013132256A1 Compositions and methods for treating viral-mediated infection and disease in immunocompromised individuals |
| 09/12/2013 | WO2013132208A1 Pharmaceutical antiretroviral combinations comprising lamivudine, festinavir and nevirapine |
| 09/12/2013 | WO2013132052A1 Compositions comprising secretory - like immunoglobulins |
| 09/12/2013 | WO2013132014A1 Semisynthetic derivatives of nystatin a1 |
| 09/12/2013 | WO2013131565A1 Novel veterinary vaccine |
| 09/12/2013 | WO2013131496A1 Component and method for treating viral disease |
| 09/12/2013 | WO2013131409A1 Phenyl-oxazolyl derivatives, preparation method thereof, and related application of the phenyl-oxazolyl derivatives as an impdh inhibitor |
| 09/12/2013 | WO2013131182A1 Guanosine-rich oligonucleotide (gro) compostions, methods and uses for treating respiratory syncytial virus infection |
| 09/12/2013 | WO2013131143A1 Micrornas and uses thereof |
| 09/12/2013 | WO2013084214A3 Pyrazinoic acid prodrugs activated by esterases of mycobacteria |
| 09/12/2013 | US20130237491 4'-substituted nucleoside derivatives as inhibitors of hcv rna replication |
| 09/12/2013 | US20130237490 Novel antibacterial compounds, methods of making them, and uses thereof |
| 09/12/2013 | US20130236565 Topical formulations |
| 09/12/2013 | US20130236514 Pharmaceutical Compositions Comprising Terbinafine |
| 09/11/2013 | EP2636735A1 Recombinant vaccinia virus having hemagglutinin protein genes derived from novel influenza viruses |
| 09/11/2013 | EP2636682A1 Compositions comprising secretory-like immunoglobulins |
| 09/11/2013 | EP2636409A1 Combined pharmaceutical composition as antifungal agent |
| 09/11/2013 | EP2635570A2 Novel specific hcv ns3 protease inhibitors |
| 09/11/2013 | EP2635305A1 Enhancement of pathogen-specific memory th17 cell responses |
| 09/11/2013 | EP2635274A1 Anti-staphylococcal celecoxib derivatives |
| 09/11/2013 | EP2635260A2 Compositions and methods for the delivery of therapeutics |
| 09/11/2013 | CN1678345B Multi plasmid system for the production of influenza virus |
| 09/11/2013 | CN103298936A Recombinant vaccinia virus having hemagglutinin protein genes derived from novel influenza viruses |
| 09/11/2013 | CN103298924A Probiotic composition for oral health |
| 09/11/2013 | CN103298791A 病毒聚合酶抑制剂 Viral polymerase inhibitors |
| 09/11/2013 | CN103298780A Hydroxamic acid derivatives and their use in the treatment of bacterial infections |
| 09/11/2013 | CN103298485A Multivalent vaccine for filariasis |
| 09/11/2013 | CN103298475A Design of oligonucleotide analogs as therapeutic agents |
| 09/11/2013 | CN103293316A A method of diagnosis and treatment |
| 09/11/2013 | CN103290049A Small-ring type DNA (deoxyribonucleic acid) recombinant vector for blocking HIV (human immunodeficiency virus)-1 membrane fusion and application thereof |
| 09/11/2013 | CN103289986A Cattle Brucella recombination strain S19-delta bp 26-BL and preparation method and application thereof |
| 09/11/2013 | CN103289980A Protease screening methods and proteases indentified thererby |
| 09/11/2013 | CN103289966A Low virulent strain of pig Japanese encephalitis virus |
| 09/11/2013 | CN103289963A Bacteriophage with environment disinfection capability and applications thereof |
| 09/11/2013 | CN103289944A Genetic engineering preparation method and application for streptococcus lactis secreting antibacterial peptide |
| 09/11/2013 | CN103289918A A bdellovibrio bacteriovorus preparation, and a fermentation method and applications thereof |
| 09/11/2013 | CN103289917A A bdellovibrio bacteriovorus preparation, and a fermentation method and applications thereof |
| 09/11/2013 | CN103289038A Star-like oxazolidine latent curing agent and preparation method as well as use thereof |
| 09/11/2013 | CN103288949A Interferon alpha mutant and polyethylene glycol derivative thereof |
| 09/11/2013 | CN103288948A Interferon alpha mutant and polyethylene glycol derivative thereof |
| 09/11/2013 | CN103288947A Interferon alpha mutant and polyethylene glycol derivative thereof |
| 09/11/2013 | CN103288934A Haemophilus parasuis immunoprotective antigen HbpA |
| 09/11/2013 | CN103288933A Haemophilus parasuis immunoprotective antigen CdtC |
| 09/11/2013 | CN103288931A Immunogenic polypeptides for human papillomavirus as well as preparation method and application of same |
| 09/11/2013 | CN103288928A Bacillus mojavensis, antifungal lipopeptide compound, and preparation as well as application thereof |
| 09/11/2013 | CN103288897A 4'-O-(1-aralkyl-1,2,3-triazole-4-methyl-formamyl) azithromycin derivatives |
| 09/11/2013 | CN103288857A Sarafloxacin metal complex and preparation method thereof |
| 09/11/2013 | CN103288854A Cefazolin sodium pentahydrate compound and preparation method and medicine composition thereof |
| 09/11/2013 | CN103288832A Pyrrolopyridazine compounds with antiviral properties |
| 09/11/2013 | CN103288816A Mannich alkali compounds containing phenothiazine group and 1,3,4-thiadiazole group as well as preparation method and application thereof |
| 09/11/2013 | CN103288815A Beta-lactamyl vasopression V1a antagonists |
| 09/11/2013 | CN103288764A Quinhydroxy ketone glycine ester hydrochloride and preparation method thereof |
| 09/11/2013 | CN103288747A 6-Cyclohexylmethyl-2-aromatic ring carbonyl substituted N-DABO compounds, and synthetic method and use thereof |
| 09/11/2013 | CN103288719A Synthesis of non-nucleoside HIV (human immunodeficiency virus) inhibitor pyridone lead |
| 09/11/2013 | CN103285418A Novel biological antibacterial dressing aerosol based on large-area burn wound |
| 09/11/2013 | CN103285416A Chitosan antibacterial wound protection film |
| 09/11/2013 | CN103285399A Freezing and drying protecting agent for amyxis brucella live vaccine |
| 09/11/2013 | CN103285396A Medicine composition for eradicating helicobacter pylori, as well as preparation method and application |
| 09/11/2013 | CN103285393A Egg yolk antibody microcapsule for resisting hand-foot-and-mouth disease, and preparation method thereof |
| 09/11/2013 | CN103285391A Combined vaccine of seasonal influenza and pandemic influenza for people and preparation method |
| 09/11/2013 | CN103285390A Method for preparing rabies vaccine |
| 09/11/2013 | CN103285387A PCV2 immunogenic compositions and methods of producing such compositions |
| 09/11/2013 | CN103285386A Immunisation method against 4 dengue serotypes |
| 09/11/2013 | CN103285385A Method for preparing porcine circovirus 2-type inactivated vaccine |
| 09/11/2013 | CN103285383A Pharmaceutical composition comprising bromelain and bromelain enteric-coated tablet |
| 09/11/2013 | CN103285374A Amoxicillin colistin sulphate granule and preparation method thereof |
| 09/11/2013 | CN103285371A Antibacterial peptide stable preparation and preparation method thereof |
| 09/11/2013 | CN103285366A Chinese and western combination medicament for treating toothache |
| 09/11/2013 | CN103285350A Traditional Chinese medicine for treating viral cold and preparation method thereof |
| 09/11/2013 | CN103285304A Medicine for treating infection after lung cancer chemotherapy |
| 09/11/2013 | CN103285296A Traditional Chinese medicine for treating phthisis |
| 09/11/2013 | CN103285295A Traditional Chinese medicine preparation |
| 09/11/2013 | CN103285286A Preparation method of fermented medicine for treating foot and hand tinea |